Wolfe Research analyst Justin Lake confirmed with Humana (HUM) that the company has submitted a proposal for summary judgement to the judge in ...

State police confirmed the man who died after falling through the ice Sunday on the Great Sacandaga Lake was William Gifford.

On Friday, Wolfe Research adjusted its rating on Enterprise Products Partners (NYSE:EPD) stock, downgrading it from Outperform to Peer Perform. The reevaluation comes amid a backdrop where the ...

On Friday, Wolfe Research reiterated an Outperform rating on Roku Inc. (NASDAQ:ROKU) stock, maintaining a $93.00 price target. Trading at $83 with a market capitalization of $12.05 billion ...

Enterprise Products Partners (EPD – Research Report) received a Hold rating and price target from Wolfe Research analyst Keith Stanley yesterday. The company’s shares closed last Wednesday at ...

Blake Lively and Justin Baldoni's legal war is only beginning. The former co-stars, who drew buzz and controversy with their roles in the romantic drama "It Ends with Us," allege that behind the ...

On Wednesday, Wolfe Research changed its stance on Reliance Steel & Aluminum (NYSE:RS), moving the rating up from Underperform to Peer Perform following a notable decline in the company's share price.

Perez’s longtime friend Kendall Jenner also attended the party at Lucky Strike on Jan. 4 PhotosByDutch / SplashNews.com Justin Bieber and wife Hailey Bieber kept it casual to celebrate a friend.

DoorDash (NASDAQ:DASH – Get Free Report) had its price target increased by research analysts at Wolfe Research from $210.00 to $220.00 in a note issued to investors on Friday,Benzinga reports.

Her work has previously appeared in digital publications like Paper Magazine and TV Insider. Justin Bieber/Instagram Justin Bieber is starting 2025 by showing affection for wife Hailey Baldwin Bieber.

There’s a new twist in the dispute between actors Blake Lively and Justin Baldoni, and it says a lot more about our society than it does about them. The response to the story was gigantic—in ...

Fintel reports that on January 3, 2025, Wolfe Research downgraded their outlook for Immunovant (NasdaqGS:IMVT) from Outperform to Peer Perform. Analyst Price Forecast Suggests 103.14% Upside As of ...